Global Levonorgestrel API Market Size, Share, Trends and Forecast 2022-2030

Description

Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
Industry Insights

Due to the COVID-19 pandemic, the global Levonorgestrel API market size is estimated to be worth US$ 48 million in 2021 and is forecast to a readjusted size of US$ 63 million by 2028 with a CAGR of 4.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Levonorgestrel API market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Levonorgestrel API landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

By type, the Global Levonorgestrel API market share is the highest in the short-acting contraceptive API, about 67.17%. The most proportion of the Global Levonorgestrel API market share is used for Levonorgestrel Tablet and the proportion is about 52.74% in 2020.

This report focuses on Levonorgestrel API volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Levonorgestrel API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: Europe, China, India and China Taiwan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Levonorgestrel API market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Short-Acting Contraceptive API

Long-Acting Contraceptive API

Segment by Application

Levonorgestrel Tablet

Mixture Products

Hormone-releasing IUD

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Bayer HealthCare

Qinhuangdao Zizhu Pharmaceutical

Yangzhou Pharmaceutical

Lupin

Hubei Gedian Humanwell

Sterling Spa

Formos

Huazhong Pharm

ASG Biochem

TABLE OF CONTENT

1 Levonorgestrel API Market Overview
1.1 Product Overview and Scope of Levonorgestrel API

1.2 Levonorgestrel API Segment by Type

1.2.1 Global Levonorgestrel API Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Short-Acting Contraceptive API

1.2.3 Long-Acting Contraceptive API

1.3 Levonorgestrel API Segment by Application

1.3.1 Global Levonorgestrel API Sales Comparison by Application: (2022-2028)

1.3.2 Levonorgestrel Tablet

1.3.3 Mixture Products

1.3.4 Hormone-releasing IUD

1.4 Global Levonorgestrel API Market Size Estimates and Forecasts

1.4.1 Global Levonorgestrel API Revenue 2017-2028

1.4.2 Global Levonorgestrel API Sales 2017-2028

1.4.3 Levonorgestrel API Market Size by Region: 2017 Versus 2021 Versus 2028

2 Levonorgestrel API Market Competition by Manufacturers

2.1 Global Levonorgestrel API Sales Market Share by Manufacturers (2017-2022)

2.2 Global Levonorgestrel API Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Levonorgestrel API Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Levonorgestrel API Manufacturing Sites, Area Served, Product Type

2.5 Levonorgestrel API Market Competitive Situation and Trends

2.5.1 Levonorgestrel API Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Levonorgestrel API Players Market Share by Revenue

2.5.3 Global Levonorgestrel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Levonorgestrel API Retrospective Market Scenario by Region

3.1 Global Levonorgestrel API Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Levonorgestrel API Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Levonorgestrel API Market Facts & Figures by Country

3.3.1 North America Levonorgestrel API Sales by Country

3.3.2 North America Levonorgestrel API Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Levonorgestrel API Market Facts & Figures by Country

3.4.1 Europe Levonorgestrel API Sales by Country

3.4.2 Europe Levonorgestrel API Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Levonorgestrel API Market Facts & Figures by Region

3.5.1 Asia Pacific Levonorgestrel API Sales by Region

3.5.2 Asia Pacific Levonorgestrel API Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Levonorgestrel API Market Facts & Figures by Country

3.6.1 Latin America Levonorgestrel API Sales by Country

3.6.2 Latin America Levonorgestrel API Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Levonorgestrel API Market Facts & Figures by Country

3.7.1 Middle East and Africa Levonorgestrel API Sales by Country

3.7.2 Middle East and Africa Levonorgestrel API Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Levonorgestrel API Historic Market Analysis by Type

4.1 Global Levonorgestrel API Sales Market Share by Type (2017-2022)

4.2 Global Levonorgestrel API Revenue Market Share by Type (2017-2022)

4.3 Global Levonorgestrel API Price by Type (2017-2022)

5 Global Levonorgestrel API Historic Market Analysis by Application

5.1 Global Levonorgestrel API Sales Market Share by Application (2017-2022)

5.2 Global Levonorgestrel API Revenue Market Share by Application (2017-2022)

5.3 Global Levonorgestrel API Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Bayer HealthCare

6.1.1 Bayer HealthCare Corporation Information

6.1.2 Bayer HealthCare Description and Business Overview

6.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Bayer HealthCare Levonorgestrel API Product Portfolio

6.1.5 Bayer HealthCare Recent Developments/Updates

6.2 Qinhuangdao Zizhu Pharmaceutical

6.2.1 Qinhuangdao Zizhu Pharmaceutical Corporation Information

6.2.2 Qinhuangdao Zizhu Pharmaceutical Description and Business Overview

6.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Portfolio

6.2.5 Qinhuangdao Zizhu Pharmaceutical Recent Developments/Updates

6.3 Yangzhou Pharmaceutical

6.3.1 Yangzhou Pharmaceutical Corporation Information

6.3.2 Yangzhou Pharmaceutical Description and Business Overview

6.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Yangzhou Pharmaceutical Levonorgestrel API Product Portfolio

6.3.5 Yangzhou Pharmaceutical Recent Developments/Updates

6.4 Lupin

6.4.1 Lupin Corporation Information

6.4.2 Lupin Description and Business Overview

6.4.3 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Lupin Levonorgestrel API Product Portfolio

6.4.5 Lupin Recent Developments/Updates

6.5 Hubei Gedian Humanwell

6.5.1 Hubei Gedian Humanwell Corporation Information

6.5.2 Hubei Gedian Humanwell Description and Business Overview

6.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Hubei Gedian Humanwell Levonorgestrel API Product Portfolio

6.5.5 Hubei Gedian Humanwell Recent Developments/Updates

6.6 Sterling Spa

6.6.1 Sterling Spa Corporation Information

6.6.2 Sterling Spa Description and Business Overview

6.6.3 Sterling Spa Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Sterling Spa Levonorgestrel API Product Portfolio

6.6.5 Sterling Spa Recent Developments/Updates

6.7 Formos

6.6.1 Formos Corporation Information

6.6.2 Formos Description and Business Overview

6.6.3 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Formos Levonorgestrel API Product Portfolio

6.7.5 Formos Recent Developments/Updates

6.8 Huazhong Pharm

6.8.1 Huazhong Pharm Corporation Information

6.8.2 Huazhong Pharm Description and Business Overview

6.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Huazhong Pharm Levonorgestrel API Product Portfolio

6.8.5 Huazhong Pharm Recent Developments/Updates

6.9 ASG Biochem

6.9.1 ASG Biochem Corporation Information

6.9.2 ASG Biochem Description and Business Overview

6.9.3 ASG Biochem Levonorgestrel API Sales, Revenue and Gross Margin (2017-2022)

6.9.4 ASG Biochem Levonorgestrel API Product Portfolio

6.9.5 ASG Biochem Recent Developments/Updates

7 Levonorgestrel API Manufacturing Cost Analysis

7.1 Levonorgestrel API Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Levonorgestrel API

7.4 Levonorgestrel API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Levonorgestrel API Distributors List

8.3 Levonorgestrel API Customers

9 Levonorgestrel API Market Dynamics

9.1 Levonorgestrel API Industry Trends

9.2 Levonorgestrel API Market Drivers

9.3 Levonorgestrel API Market Challenges

9.4 Levonorgestrel API Market Restraints

10 Global Market Forecast

10.1 Levonorgestrel API Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Levonorgestrel API by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Levonorgestrel API by Type (2023-2028)

10.2 Levonorgestrel API Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Levonorgestrel API by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Levonorgestrel API by Application (2023-2028)

10.3 Levonorgestrel API Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Levonorgestrel API by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Levonorgestrel API by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample